↓ Skip to main content

Unique perception of clinical trials by Korean cancer patients

Overview of attention for article published in BMC Cancer, December 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Unique perception of clinical trials by Korean cancer patients
Published in
BMC Cancer, December 2012
DOI 10.1186/1471-2407-12-594
Pubmed ID
Authors

Su Jin Lee, Lee Chun Park, Jeeyun Lee, Seonwoo Kim, Moon Ki Choi, Jung Yong Hong, Sylvia Park, Chi Hoon Maeng, Wonjin Chang, Young Saing Kim, Se Hoon Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Young Suk Park

Abstract

In the past few years, the number of clinical trials has increased rapidly in East Asia, especially for gastric and hepatobiliary cancer that are prevalent in Asian populations. However, the actual degree of understanding or perceptions of clinical trials by cancer patients in East Asian countries have seldom been studied.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 21%
Student > Bachelor 8 21%
Student > Master 6 15%
Researcher 4 10%
Student > Postgraduate 4 10%
Other 4 10%
Unknown 5 13%
Readers by discipline Count As %
Medicine and Dentistry 15 38%
Social Sciences 5 13%
Agricultural and Biological Sciences 3 8%
Nursing and Health Professions 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Other 5 13%
Unknown 7 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2012.
All research outputs
#3,544,048
of 5,032,959 outputs
Outputs from BMC Cancer
#1,764
of 2,816 outputs
Outputs of similar age
#188,095
of 285,447 outputs
Outputs of similar age from BMC Cancer
#64
of 108 outputs
Altmetric has tracked 5,032,959 research outputs across all sources so far. This one is in the 16th percentile – i.e., 16% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,816 research outputs from this source. They receive a mean Attention Score of 2.6. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,447 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.